Detalles de la búsqueda
1.
The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention.
Int J Mol Sci
; 23(15)2022 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35897717
2.
Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents.
Bioorg Med Chem
; 42: 116251, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34116381
3.
Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types.
Invest New Drugs
; 37(2): 252-261, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29947013
4.
Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair.
Tumour Biol
; 36(11): 8985-92, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26081617
5.
Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives.
iScience
; 27(1): 108659, 2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235331
6.
Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors.
Ann Med
; 55(1): 2203946, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37092854
7.
Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: Does sequence matter?
Front Pharmacol
; 13: 938471, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36120345
8.
Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells.
Toxicol Appl Pharmacol
; 255(3): 271-86, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21763710
9.
Recent advances in management of COVID-19: A review.
Biomed Pharmacother
; 143: 112107, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34488083
10.
Targeting DNA double-strand break repair: is it the right way for sensitizing cells to 5-fluorouracil?
Anticancer Drugs
; 21(3): 277-87, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20075715
11.
Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate-4-thiazolinone hybrid derivatives.
Biomed Pharmacother
; 131: 110571, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32861966
12.
Apoptosis is the most efficient death-pathway in tumor cells after topoisomerase II inhibition.
Saudi Med J
; 29(4): 558-64, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18382799
13.
Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin.
Cancer Biol Ther
; 19(1): 25-33, 2018 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29244610
14.
Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy.
Cancers (Basel)
; 11(1)2018 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30583472
15.
In-silico screening for DNA-dependent protein kinase (DNA-PK) inhibitors: Combined homology modeling, docking, molecular dynamic study followed by biological investigation.
Biomed Pharmacother
; 83: 693-703, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27470570
16.
The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.
Front Pharmacol
; 7: 535, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28119610
17.
Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.
Cancer Biol Ther
; 16(7): 1056-70, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25962089
18.
Induction and repair of DNA double-strand breaks using constant-field gel electrophoresis and apoptosis as predictive markers for sensitivity of cancer cells to cisplatin.
Biomed Pharmacother
; 66(7): 554-62, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22939736
19.
Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways.
Cancer Biol Ther
; 13(11): 1058-71, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22895066
20.
Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Cell Biochem Biophys
; 55(2): 95-105, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19593673